{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:05:38Z","timestamp":1794002738097,"version":"4.8.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Red cell exchange transfusions remain an effective but possibly underutilized therapy in the acute and chronic treatment of sickle cell disease. In sickle cell disease, increased blood viscosity can cause complications when the hemoglobin exceeds 10 g\/dL even if this is due to simple transfusion. Red cell exchange can provide needed oxygen carrying capacity while reducing the overall viscosity of blood. Acute red cell exchange is useful in acute infarctive stroke, in acute chest and the multi-organ failure syndromes, the right upper quadrant syndrome, and possibly priapism. Neither simple or exchange transfusions are likely to hasten resolution of an acute pain episode.<\/jats:p>","DOI":"10.1182\/asheducation-2006.1.48","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T23:14:02Z","timestamp":1164237242000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":139,"title":["Red Cell Exchange in Sickle Cell Disease"],"prefix":"10.1182","volume":"2006","author":[{"given":"Paul S.","family":"Swerdlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111704461537500_R1","doi-asserted-by":"crossref","unstructured":"Huber H et al: The influence of anaemia, polycythaemia and splenomegaly on the relationship between venous hematocrit and red cell volume. Br J Hematol. 1964;10:576.","DOI":"10.1111\/j.1365-2141.1964.tb00733.x"},{"key":"2019111704461537500_R2","unstructured":"Erslev AJ, Gabuzda TG. Pathophysiology of Blood. 3rd ed. WBSanders Company: Philadelphia; 1985."},{"key":"2019111704461537500_R3","doi-asserted-by":"crossref","unstructured":"Schmalzer EA, Lee JO, Brown AK, Usami S, Chien S. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion. 1987;27:228\u2013233.","DOI":"10.1046\/j.1537-2995.1987.27387235626.x"},{"key":"2019111704461537500_R4","unstructured":"Dintenfass L. Rheology of packed red blood cells containing hemoglobins A-A, S-A and S-S. J Lab Clin Med. 1964;64(4):594\u2013600."},{"key":"2019111704461537500_R5","doi-asserted-by":"crossref","unstructured":"Steinberg MH, Adams JG, Lovell WJ. Sickle cell anemia: erythrokinetics, blood volumes, and a study of possible determinants of severity. Am J Hematol. 1977;2:17\u201323.","DOI":"10.1002\/ajh.2830020103"},{"key":"2019111704461537500_R6","doi-asserted-by":"crossref","unstructured":"Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Protein Chem. 1990;40:63\u2013279.","DOI":"10.1016\/S0065-3233(08)60287-9"},{"key":"2019111704461537500_R7","unstructured":"Nagel RL, Platt OS. General pathophysiology of sickle cell anemia. In: Steinberg MH, Forget BG, Diggs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge University Press; 2001."},{"key":"2019111704461537500_R8","doi-asserted-by":"crossref","unstructured":"Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762\u2013769.","DOI":"10.1056\/NEJM199709113371107"},{"key":"2019111704461537500_R9","unstructured":"Kaul DK, Fabry ME. In vivo studies of sickle red blood cells. Microcirculation. 2004;11:153\u2013165."},{"key":"2019111704461537500_R10","doi-asserted-by":"crossref","unstructured":"Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279\u20132285.","DOI":"10.1182\/blood-2005-06-2373"},{"key":"2019111704461537500_R11","unstructured":"The Management of Sickle Cell Disease, NIH Publication No. 02\u20132117, 4th edition, 2002."},{"key":"2019111704461537500_R12","unstructured":"Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855\u20131865. Erratum in: N Engl J Med 2000;343: 824."},{"key":"2019111704461537500_R13","doi-asserted-by":"crossref","unstructured":"Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med1994;96:155\u2013162.","DOI":"10.1016\/0002-9343(94)90136-8"},{"key":"2019111704461537500_R14","doi-asserted-by":"crossref","unstructured":"Ballas SK. Sickle cell disease: current clinical management. Semin Hematol. 2001;38:307\u2013301.","DOI":"10.1016\/S0037-1963(01)90024-1"},{"key":"2019111704461537500_R15","unstructured":"Telen MJ. Principles and problems of transfusion in sickle cell disease. Sem. Hematol. 2001;38:315\u2013323."},{"key":"2019111704461537500_R16","doi-asserted-by":"crossref","unstructured":"Rackoff WR, Ohene-Frempong K, Month S, et al. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr. 1992;120:882\u2013885.","DOI":"10.1016\/S0022-3476(05)81954-7"},{"key":"2019111704461537500_R17","doi-asserted-by":"crossref","unstructured":"Siegel JP, Rich MA, Brock WA. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol. 1993;150:1480\u20131482.","DOI":"10.1016\/S0022-5347(17)35817-2"},{"key":"2019111704461537500_R18","unstructured":"Ballas SK, Lyon D, Hall N, Kent T. Safety of blood exchange transfusion for priapism complicating sickle cell disease. J Clin Apher. 2006;21:16."},{"key":"2019111704461537500_R19","doi-asserted-by":"crossref","unstructured":"Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333:206\u2013213.","DOI":"10.1056\/NEJM199507273330402"},{"key":"2019111704461537500_R20","doi-asserted-by":"crossref","unstructured":"Neumayr L, Koshy M, Haberkern C, et al. Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group. Am J Hematol. 1998;57:101\u2013108.","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<101::AID-AJH2>3.0.CO;2-#"},{"key":"2019111704461537500_R21","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis JA, Meertens JH, Zijlstra JG, Ligtenberg JJ, Tulleken JE, van der Werf TS. Automated erythrocytapheresis in severe falciparum malaria: a critical appraisal. Acta Trop. 2006; Jun 7[Epub ahead of print]","DOI":"10.1016\/j.actatropica.2006.05.003"},{"key":"2019111704461537500_R22","doi-asserted-by":"crossref","unstructured":"Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med. 1988;319:1447\u20131452.","DOI":"10.1056\/NEJM198812013192204"},{"key":"2019111704461537500_R23","doi-asserted-by":"crossref","unstructured":"Morrison JC, Morrison FS, Floyd RC, Roberts WE, Hess LW, Wiser WL. Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease. J Clin Apher. 1991;6:224\u2013229.","DOI":"10.1002\/jca.2920060411"},{"key":"2019111704461537500_R24","doi-asserted-by":"crossref","unstructured":"Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood. 1994;83:136\u2013142.","DOI":"10.1182\/blood.V83.4.1136.1136"},{"key":"2019111704461537500_R25","doi-asserted-by":"crossref","unstructured":"Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatric Hematol Oncol. 1996;18(1):46\u201350.","DOI":"10.1097\/00043426-199602000-00009"},{"key":"2019111704461537500_R26","doi-asserted-by":"crossref","unstructured":"Hilliard LM, Williams BF, Lounsbury AE, Howard TH. Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients. Am J Hematol. 1998;59:28\u201335.","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<28::AID-AJH6>3.0.CO;2-1"},{"key":"2019111704461537500_R27","doi-asserted-by":"crossref","unstructured":"Singer ST, Quirolo K, Nishi K, Hackney-Stephens E, Evans C, Vichinsky EP. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher. 1999;14(3):122\u2013125.","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<122::AID-JCA3>3.0.CO;2-A"},{"key":"2019111704461537500_R28","doi-asserted-by":"crossref","unstructured":"Treadwell MJ, Law AW, Sung J, et al. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer. 2005;44:500\u2013507.","DOI":"10.1002\/pbc.20290"},{"key":"2019111704461537500_R29","doi-asserted-by":"crossref","unstructured":"Kim HC. Therapeutic pediatric apheresis. J Clin Apheresis. 2000;15:129\u2013157.","DOI":"10.1002\/(SICI)1098-1101(2000)15:1\/2<129::AID-JCA7>3.0.CO;2-H"},{"key":"2019111704461537500_R30","doi-asserted-by":"crossref","unstructured":"Raes A, Van Aken S, Craen M, Donckerwolcke R, Vande Walle J. A reference frame for blood volume in children and adolescents. BMC Pediatrics. 2006;6:3.","DOI":"10.1186\/1471-2431-6-3"},{"key":"2019111704461537500_R31","unstructured":"Ohene-Frempong K, Steinberg MH. Clinical aspects of sickle cell anemia in adults and children. In: Steinberg MH, Forget BG. Diggs DR. Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge University Press; 2001."},{"key":"2019111704461537500_R32","doi-asserted-by":"crossref","unstructured":"Eckman JR. Techniques for blood administration in sickle cell patients. Semin Hematol. 2001;38:23\u201329.","DOI":"10.1016\/S0037-1963(01)90057-5"},{"key":"2019111704461537500_R33","doi-asserted-by":"crossref","unstructured":"Weinstein R. Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange. J Clin Apher. 2001;16(4):210\u2013211.","DOI":"10.1002\/jca.10000"},{"key":"2019111704461537500_R34","unstructured":"Vishnubhotla PS, Zielinski I, Swerdlow P. Use of monthly central venous catheter placement for patients on chronic red cell exchange in sickle cell disease [abstract]. Blood. 2003;102(11):760a."},{"key":"2019111704461537500_R35","doi-asserted-by":"crossref","unstructured":"McCready CE, Doughty HA, Pearson TC. Experience with the Port-A-Cath in sickle cell disease. Clin Lab Haematol. 1996;2:79\u201382.","DOI":"10.1046\/j.1365-2257.1996.00154.x"},{"key":"2019111704461537500_R36","doi-asserted-by":"crossref","unstructured":"Jeng MR, Feusner J, Skibola C, et al. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002;692:103\u2013108.","DOI":"10.1002\/ajh.10047"},{"key":"2019111704461537500_R37","unstructured":"Jones R. Use of vortex MP ports in therapeutic red cell exchanges [abstract]. J Clin Apheresis. 2006;21:43."},{"key":"2019111704461537500_R38","unstructured":"Van Kirk R, Koncsol J, Gutin H, Villella A, Downes KA. A single-center experience with double and single lumen vortex ports for chronic erythrocytopheresis in pediatric patients with sickle cell anemia [abstract]. J Clin Apheresis. 2006;21:42."},{"key":"2019111704461537500_R39","unstructured":"Walker S, Mayo C. Flow rates and maintenance of dual implantable ports in pediatric patients with sickle cell anemia [abstract]. J Clin Apheresis. 2006;21:44."}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2006\/1\/48\/1091379\/048_053ash.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2006\/1\/48\/1091379\/048_053ash.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T09:46:32Z","timestamp":1573983992000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2006\/1\/48\/19692\/Red-Cell-Exchange-in-Sickle-Cell-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2006.1.48","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}